These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15581268)

  • 1. ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.
    Billeter M;
    Am J Health Syst Pharm; 2004 Nov; 61(22):2430-5. PubMed ID: 15581268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.
    Couch KA; Geide T
    Am J Health Syst Pharm; 2014 Mar; 71(5):417-24. PubMed ID: 24534597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].
    Aguilar L; Giménez MJ
    Rev Esp Quimioter; 2007 Mar; 20(1):125-7. PubMed ID: 17530045
    [No Abstract]   [Full Text] [Related]  

  • 4. Changing trends in antimicrobial-resistant pneumococci: it's not all bad news.
    Low DE
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S228-33. PubMed ID: 16032557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.
    Am J Health Syst Pharm; 1997 Mar; 54(5):575-8. PubMed ID: 9066871
    [No Abstract]   [Full Text] [Related]  

  • 6. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.
    Zhao C; Li Z; Zhang F; Zhang X; Ji P; Zeng J; Hu B; Hu Z; Liao K; Sun H; Zhang R; Cao B; Zhuo C; Jia W; Mei Y; Chu Y; Xu X; Yang Q; Jin Y; Fu Q; Xu X; Li H; Wang L; Ni Y; Liang H; Wang H
    BMC Infect Dis; 2017 Dec; 17(1):804. PubMed ID: 29284419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal resistance in the postvaccine era.
    Temime L; Guillemot D; Boëlle PY
    Pediatr Infect Dis J; 2006 Apr; 25(4):382-3. PubMed ID: 16568001
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the burden of pneumococcal disease in adults.
    Blasi F; Mantero M; Santus P; Tarsia P
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():7-14. PubMed ID: 22882668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
    Nuermberger EL; Bishai WR
    Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: the Palestinian-Israeli Collaborative Research (PICR).
    Daana M; Rahav G; Hamdan A; Thalji A; Jaar F; Abdeen Z; Jaber H; Goral A; Huppert A; Raz M; Regev-Yochay G;
    Vaccine; 2015 Feb; 33(8):1021-6. PubMed ID: 25593104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The continuing problem of pneumococcal infection.
    Davies AJ; Kumaratne DS
    J Antimicrob Chemother; 1988 Apr; 21(4):387-91. PubMed ID: 3288603
    [No Abstract]   [Full Text] [Related]  

  • 13. Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States.
    Andam CP; Worby CJ; Gierke R; McGee L; Pilishvili T; Hanage WP
    Emerg Infect Dis; 2017 Jun; 23(6):1012-1015. PubMed ID: 28518018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An update of Streptococcus pneumoniae: from genomic to clinic].
    Wintenberger C
    Med Mal Infect; 2010 Oct; 40(10):605-9. PubMed ID: 20934286
    [No Abstract]   [Full Text] [Related]  

  • 15. Macrolide Resistance in
    Schroeder MR; Stephens DS
    Front Cell Infect Microbiol; 2016; 6():98. PubMed ID: 27709102
    [No Abstract]   [Full Text] [Related]  

  • 16. Action plan for drug-resistant Streptococcus pneumoniae. The DRSP Working Group.
    Cetron MS; Jernigan DB; Breiman RF
    Emerg Infect Dis; 1995; 1(2):64-5. PubMed ID: 8903164
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece.
    Maraki S; Mantadakis E; Samonis G
    Chemotherapy; 2010; 56(4):325-32. PubMed ID: 20720416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
    Singh J; Sundaresan S; Manoharan A; Shet A
    Vaccine; 2017 Aug; 35(35 Pt B):4501-4509. PubMed ID: 28711387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
    Lynch JP; Zhanel GG
    Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.